Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.08.30.505806

Phylogenomics of globally spread Clonal Groups 14 and 15 of Klebsiella pneumoniae

Abstract

The increasing worldwide spread of multidrug-resistant (MDR) Kp is largely driven by high-risk sublineages, some of them well-characterised such as Clonal Group (CG) 258, CG147 or CG307. MDR Kp Sequence-Type (ST) 14 and ST15 have been described worldwide causing frequent outbreaks of CTX-M-15 and/or carbapenemase producers. However, their phylogeny, population structure and global dynamics remain unclear. Here, we clarify the phylogenetic structure and evolvability of CG14 and CG15 Kp by analysing the CG14 and CG15 genomes available in public databases (n=481, November 2019) and de novo sequences representing main sublineages circulating in Portugal (n=9). Deduplicated genomes (n=235) were used to infer temporal phylogenetic evolution and to compare their capsular locus (KL), resistome, virulome and plasmidome using high-resolution tools. Phylogenetic analysis supported independent evolution of CG14 and CG15 within two distinct clades and 4 main subclades which are mainly defined according to the KL and the accessory genome. Within CG14, two large monophyletic subclades, KL16 (14%) and KL2 (86%), presumptively emerged around 1937 and 1942, respectively. Sixty-five percent of CG14 carried genes encoding ESBL, AmpC and/or carbapenemases and, remarkably, they were mainly observed in the KL2 subclade. The CG15 clade was segregated in two major subclades. One was represented by KL24 (42%) and KL112 (36%), the latter one diverging from KL24 around 1981, and the other comprised KL19 and other KL-types (16%). Of note, most CG15 genomes contained genes encoding ESBL, AmpC and/or carbapenemases (n=148, 87%) and displayed a characteristic set of mutations in regions encoding quinolone resistance (QRDR, GyrA83F/GyrA87A/ParC80I). Plasmidome analysis revealed 2463 plasmids grouped in 27 predominant plasmid groups (PG) with a high degree of recombination, including particularly pervasive F-type (n=10) and Col (n=10) plasmids. Whereas blaCTX-M-15 was linked to a high diversity of mosaic plasmids, other ARGs were confined to particular plasmids (e.g. blaOXA-48-IncL; blaCMY/TEM-24-IncC). This study firstly demonstrates an independent evolutionary trajectory for CG15 and CG14, and suggests how the acquisition of specific KL, QRDR mutations (CG15) and ARGs in highly recombinant plasmids could have shaped the expansion and diversification of particular subclades (CG14-KL2, CG15-KL24/KL112). IMPORTANCEKlebsiella pneumoniae (Kp) represents a major threat in the burden of antimicrobial resistance (AMR). Phylogenetic approaches to explain the phylogeny, emergence and evolution of certain multidrug resistant populations have mainly focused on core-genome approaches while variation in the accessory genome and the plasmidome have been long overlooked. In this study, we provide unique insights into the phylogenetic evolution and plasmidome of two intriguing and yet uncharacterized clonal groups (CGs), the CG14 and CG15, which have contributed to the global dissemination of contemporaneous {beta}-lactamases. Our results point-out an independent evolution of these two CGs and highlight the existence of different clades structured by the capsular-type and the accessory genome. Moreover, the contribution of a turbulent flux of plasmids (especially multireplicon F type and Col) and adaptive traits (antibiotic resistance and metal tolerance genes) to the pangenome, reflect the exposure and adaptation of Kp under different selective pressures.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Rodrigues, C., Lanza, V. F., Peixe, L. V., Coque, T. M., Novais, A.. 2022-08-30. Phylogenomics of globally spread Clonal Groups 14 and 15 of Klebsiella pneumoniae. https://doi.org/10.1101/2022.08.30.505806

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

PfPHAST: Plasmodium falciparum Public Health Amplicon Sequencing Tool, a Streamlined Panel for Malaria Genomic Surveillance

Genomic tools can support malaria control policy through surveillance of Plasmodium falciparum populations, tracking antimalarial drug resistance, pfhrp2/3 deletions that compromise rapid diagnostic tests, and selection at the circumsporozoite protein (PfCSP) vaccine target, as well as through molecular correction of therapeutic efficacy studies (TES). Multiplex Amplicons for Drug, Diagnostic, Diversity, and Differentiation Haplotypes using Targeted Resequencing (MAD4HatTeR), a comprehensive amplicon sequencing panel covering up to 276 targets, supports these applications but is tailored to research rather than routine programmatic use. We developed P. falciparum Public Health Amplicon Sequencing Tool (PfPHAST), a 56-target derivative of MAD4HatTeR spanning drug resistance loci, pfhrp2/3 deletion, PfCSP genotyping, non-falciparum species identification, and 20 high-heterozygosity microhaplotype loci for TES classification. We compared PfPHAST and MAD4HatTeR using laboratory strain controls, including two-strain dilution series and a five-strain mixture, across parasite densities of 100 to 10,000 parasites/L. At matched per-target depth, PfPHAST achieved a higher quality-control pass rate than MAD4HatTeR (94.4% versus 90.0%) and distributed reads more evenly across targets. The panels showed comparable recall and precision for drug resistance codons and microhaplotypes, reaching near-complete recall above 40% within-sample allele frequency (WSAF) at all densities, with reduced sensitivity for minor alleles below 10% WSAF at low parasite density in both panels. Observed and expected WSAF correlated strongly for both panels, and both resolved a five-strain polyclonal mixture, including a 5% minor strain. By concentrating sequencing capacity on targets of greatest programmatic relevance, PfPHAST offers a scalable, lower-cost alternative to comprehensive research panels without sacrificing performance on shared targets, complementing MAD4HatTeR for routine molecular malaria surveillance.

genomics↗

Structural variation in repeat elements is widespread in normal human tissues and in tumorigenesis

Somatic mosaicism contributes to genomic variation, yet postzygotic structural variants remain under-characterized. We performed long- and short-read WGS from multiple individuals (n=47 normal tissues; n=168 samples) and identified mosaic structural variants in all individuals and germ layers, impacting a median 285.2 kb/genome. Nearly half of breakpoints were independently validated, with tissue distributions reflecting both early and late developmental origins. Most mosaic variants were repeat-mediated and 8.3% overlapped functional elements, an enrichment compared to germline variants. To extend these analyses in samples where long-read sequencing is infeasible, we measured repeat alterations from short-read sequencing, recapitulating mosaic tissue-specific differences. We characterized tumor- and tissue- specific variation in repeats across 15 cancer types and found tumor-related repeat variation to be similar in scale to that of normal mosaic variation. Tracking repeat changes in cell-free DNA provided a noninvasive approach for tumor monitoring. Our analyses revealed widespread repeat-driven structural variation in health and disease.

genomics↗

RNA isoform-resolved multiplexed sequencing with bioorthogonal barcoding

RNA isoform dysregulation drives disease pathogenesis and is the target of FDA-approved splice-switching therapeutics. However, multiplexed sequencing methods discard splice junction information because only 3' termini are barcoded and counted. Here, we repurpose acylation and click chemistries to conjugate bioorthogonal barcodes (bobcodes) directly onto multiple internal positions along cellular RNAs. Bobcoded RNAs from multiple samples are pooled for multiplexed cDNA synthesis, during which reverse transcriptase switches from each RNA template onto its tethered bobcode with greater than 99% accuracy in species mixing experiments. Bobcode attachment intervals set cDNA insert sizes without a library fragmentation step, and priming with poly(dT) or random hexamers selects between 3'-end counting and full-length isoform capture. A bioorthogonal barcode-sequencing (BOB-seq v0.1) drug screen identifies transcriptome-wide on- and off-target RNA splicing effects and outperforms existing multiplexing RNA sequencing methods in workflow simplicity, sample-to-sample variability, and barcoding accuracy. Bobcodes add isoform resolution to scalable multiplexed RNA sequencing.

genomics↗